Collegium Pharmaceutical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
CEOVikram Karnani
CEOVikram Karnani
Employees357
Employees357
HeadquartersStoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded2002
Founded2002
Employees357
Employees357
COLL Key Statistics
Market cap1.46B
Market cap1.46B
Price-Earnings ratio28.77
Price-Earnings ratio28.77
Dividend yield—
Dividend yield—
Average volume560.97K
Average volume560.97K
High today$46.70
High today$46.70
Low today$45.33
Low today$45.33
Open price$45.60
Open price$45.60
Volume391.84K
Volume391.84K
52 Week high$48.18
52 Week high$48.18
52 Week low$23.23
52 Week low$23.23
Stock Snapshot
As of today, Collegium Pharmaceutical(COLL) shares are valued at $46.23. The company's market cap stands at 1.46B, with a P/E ratio of 28.77.
As of 2025-11-28, Collegium Pharmaceutical(COLL) stock has fluctuated between $45.33 and $46.70. The current price stands at $46.23, placing the stock +2.0% above today's low and -1.0% off the high.
The Collegium Pharmaceutical(COLL)'s current trading volume is 391.84K, compared to an average daily volume of 560.97K.
In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $48.18 and a 52-week low of $23.23.
In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $48.18 and a 52-week low of $23.23.
People also own
Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.